MARATTO

article · Journal of the American Heart Association

Sex‐ and Gender‐Based Reporting in Antihypertensive Medication Literature Informing Hypertension Guidelines

202410 citationsOpen accessUniversity of Nigeria

Abstract

Incorporation of sex- and gender-based considerations in study population, analysis, or reporting of results and adverse events is not common in the antihypertensive medication literature informing international hypertension guidelines. Greater attention to sex- and gender-based factors in research is required to optimally inform management of hypertension.

Research topics

  • Sex and Gender in Healthcare
  • Pharmaceutical industry and healthcare
  • Health Systems, Economic Evaluations, Quality of Life

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1161/jaha.123.030613

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.